Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001
Clinical trial NCT05800873 · COMPLETED
Trial details
- NCT number
- NCT05800873
- Sponsor
- Everest Medicines (China) Co.,Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2026-07-22
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.